Fda label information for this drug is available at dailymed Basal cell carcinoma (bcc) (a type of skin cancer). Cemiplimab is a newer cancer treatment that has brought hope to patients with advanced skin and lung cancers It is part of an exciting group of drugs called immune checkpoint inhibitors, which help the body’s immune system fight cancer more effectively Cemiplimab is approved by the u.s Food and drug administration (fda) to treat advanced forms of skin cancers, including cutaneous squamous.
Review important safety info & full prescribing information including med guide. Libtayo will be a game changer for head and neck squamous cell cancer Fda approved in mid october
OPEN
